Day One Biopharmaceuticals Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline MODD Q3 2025 Earnings EPS Misses Expectations Stock Gains 89 Crane Company CR Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Amid Mixed Operating Trends UPBD Q1 2026 Earnings EPS Beat Surprises Market Shares Rise Modestly VirnetX VHC Q2 2025 Earnings Narrowing Loss on Zero Revenue Stock Edges Lower FR Q1 2026 Earnings Massive EPS Beat Drives Positive Market Reaction